Renalytix Plc Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket
 


Renalytix Plc  (RNLX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

RNLX's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Jun 30 2024)
2024
(Jun 30 2023)
2023
(Jun 30 2022)
2022
(Jun 30 2021)
2021
(Jun 30 2020)
2020
Y / Y Equity Change - -77.24 % -57.17 % 349.1 % -
Y / Y Net Income Change - - - - -
Return On Equity - - - - -


You need to upgrade your Flash Player


Roe Comment
In (Jun 30 2024) ROE improved to 425.97 % compare to previous year, due to net income growth.


Financial Statements
Renalytix Plc's Equity $ -8 Millions Annual RNLX's Balance sheet
Renalytix Plc's Annual Income $ -33 Millions Annual RNLX's Income Statement
Where are RNLX's Income coming from? Visit RNLX's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.